Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2019 19:15 ET | Source: Telix Pharmaceuticals Limited

Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership

MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX,...
January 23, 2019 19:15 ET | Source: Telix Pharmaceuticals Limited

Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership

MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX,...
November 26, 2018 02:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA

MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
October 14, 2018 18:00 ET | Source: Telix Pharmaceuticals Limited

Telix and ANMI Expand PSMA Imaging Partnership

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
October 02, 2018 20:00 ET | Source: Telix Pharmaceuticals Limited

Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging

INDIANAPOLIS and COLUMBUS, Ohio, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (US) Inc. (“Telix USA”), a subsidiary of Telix Pharmaceuticals Limited (ASX:TLX), a clinical-stage...
August 12, 2018 18:00 ET | Source: Telix Pharmaceuticals Limited

First Patient Imaged in Prostate Imaging Study

MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
March 26, 2018 08:00 ET | Source: Telix Pharmaceuticals Limited

Drug Master File for Prostate Imaging Product Filed with the FDA

MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on...